HbA1c - India CDSCO Medical Device Registration

HbA1c is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000198_f0db786141f00b78e5b1a8873c63a7ff_3390caefff0ea84b0486d7f3c5d95c30. This device is marketed under the brand name ichroma™ Myoglobin neo. The license holder is CPC DIAGNOSTICS PVT.LTD, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

HbA1c

UID: IMP/IVD/2022/000198_f0db786141f00b78e5b1a8873c63a7ff_3390caefff0ea84b0486d7f3c5d95c30

Brand Name

ichroma™ Myoglobin neo

License Holder

CPC DIAGNOSTICS PVT.LTD

Device Class

Class B

Approving Authority

CDSCO

Product Information

ichromaTM HbA1c Neo is a fluorescence Immunoassay (ichroma™ Myoglobin neo) for the quantitative determination of HbA1c (ichroma™ Myoglobin neo) in human whole blood. It is useful as an aid in management and monitoring of the long-term glycemic status in patients with diabetes mellitus

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Promea Therapeutics Private Limited

Class B

Brand: ichroma™ Myoglobin neo

CPC DIAGNOSTICS PVT.LTD

Class B

Class A